BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 2666885)

  • 1. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macroprolactinoma reduction and pregnancy induction with bromocriptine].
    Grimaldo J; López Espinoza E; Villanueva C; Verulo Reyes TB; Ayala AR
    Ginecol Obstet Mex; 1988 Aug; 56():213-7. PubMed ID: 3154241
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
    Ge QS; Xu L; Wang HL; Gu CX; Lin SQ; Xu YD; Yu KM; Xie YZ; Shi YF; Zang X
    Chin Med J (Engl); 1985 Aug; 98(8):543-50. PubMed ID: 3937678
    [No Abstract]   [Full Text] [Related]  

  • 9. [Macroprolactinoma resistant to bromocriptine].
    López-Espinosa E; Ayala AR; Grimaldo J; Kunhardt J; Villanueva C
    Arch Invest Med (Mex); 1989; 20(1):1-8. PubMed ID: 2669670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 11. Galactorrhea in a 14-year-old girl.
    Panamonta O; Pakawut N
    J Med Assoc Thai; 2006 Aug; 89(8):1304-7. PubMed ID: 17048445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperprolactinemia and lens opacities.
    Costagliola C; Mastropasqua L; Amato G; Carella C
    Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metergoline and bromocriptine in the management of tumoral and idiopathic hyperprolactinemia.
    Falsetti L; Roggia A; Loda G; Turla R; Scagliola T; Schimberni M; Pontiroli AE
    Horm Metab Res; 1983 Aug; 15(8):380-4. PubMed ID: 6618428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactinoma and bromocriptine therapy.
    Skaf RA
    N J Med; 1986 Jul; 83(7):455-60. PubMed ID: 3528940
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
    Jin ZM; Shi YF; Chen GL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of prolactinoma with a new dopamine agonist].
    Svoboda T; Luger A; Knosp E; Geyer G
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1224-7. PubMed ID: 1678695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.